Independent
Tenure on this board
17.4 yrs
Meeting calendar
GLSI · Annual meeting · Thursday, December 18, 2025
Greenwich Lifesciences Inc
5 nominees · 2 ballot items.
Proposals include the election of five directors to the Greenwich LifeSciences, Inc. board and the ratification of MaloneBailey LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2025.
Market cap
$279M
1Y TSR
+94.5%
Board grade
C+
Record date
Oct 28, 2025
Filing
DEF 14A
Meeting concluded · Dec 18, 2025
Follow how the vote landed and what changed on Greenwich Lifesciences Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
Proposals
On the ballot2
- 1
Election of Directors
ManagementBoard: FORElect five nominees to hold office for one year and to serve until the 2026 annual meeting.
- 2
Ratification of the Appointment of MaloneBailey LLP as Our Independent Registered Public Accounting Firm for Fiscal Year Ending December 31, 2025
ManagementBoard: FORRatify the appointment of MaloneBailey LLP to audit the company’s financial statements for the year ending December 31, 2025.
Director elections
Nominees on the ballot5
Not independent
Tenure on this board
16.5 yrs
Independent
Tenure on this board
20.0 yrs
Not independent
Tenure on this board
6.9 yrs
Independent
Tenure on this board
6.9 yrs
Ownership
Latest 13F quarterTop institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 2.0% | 298,266 | $7M |
| 2 | BlackRock, Inc. | 1.5% | 226,055 | $5M |
| 3 | BlackRock, Inc. | 1.1% | 165,639 | $4M |
| 4 | STATE STREET CORP | 0.9% | 133,875 | $3M |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 0.9% | 132,787 | $3M |
| 6 | Nuveen, LLC | 0.5% | 80,595 | $2M |
| 7 | NORTHERN TRUST CORP | 0.4% | 60,885 | $1M |
| 8 | VANGUARD PORTFOLIO MANAGEMENT LLC | 0.4% | 58,911 | $1M |
| 9 | VANGUARD FIDUCIARY TRUST CO | 0.3% | 44,908 | $1M |
| 10 | Ancora Advisors LLCActivist | 0.3% | 37,500 | $901K |
Peers
Nearest market capOther Healthcare sector meetings6
Upcoming shareholder meetings at Greenwich Lifesciences Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Indaptus Therapeutics IncINDP
Annual meeting·Aug 10, 2026·$287M
Seer IncSEER
Annual meeting·Jul 28, 2026·$119M
Aura Biosciences IncAURA
Special meeting·Aug 5, 2026·$712M
Avanos Medical IncAVNS
Special meeting·Jul 22, 2026·$1.2B
Anaptysbio IncANAB
Annual meeting·Aug 11, 2026·$1.6B
Trulieve Cannabis CorpTRLV
Special meeting·Aug 5, 2026·$1.6B
Reference
Frequently asked questions
- When is the Greenwich Lifesciences Inc 2025 annual meeting?
- Greenwich Lifesciences Inc (GLSI) holds its 2025 annual shareholder meeting on Thursday, December 18, 2025.
- What is the record date for the Greenwich Lifesciences Inc 2025 meeting?
- The record date for the Greenwich Lifesciences Inc 2025 meeting is Tuesday, October 28, 2025. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Greenwich Lifesciences Inc's 2025 meeting?
- The board is presenting 5 director nominees at the Greenwich Lifesciences Inc 2025 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Greenwich Lifesciences Inc 2025 meeting?
- Shareholders will vote on 2 proposals at the Greenwich Lifesciences Inc 2025 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.